论文部分内容阅读
以阻滞雄激素受体（ＡＲ）通道为主的内分泌治疗是晚期前列腺癌（ＰＣ）的主要治疗手段之一，但ＰＣ患者对内分泌治疗的反应性存在很大差异，目前临床上还不能预测晚期ＰＣ的预后。有作者认为癌组织中的ＡＲ水平对ＰＣ内分泌治疗具有预后判断价值〔１〕，ＡＲ基因突变是导...
Endocrine therapy, which blocks the androgen receptor (AR) pathway, is one of the major treatments for advanced prostate cancer (PC). However, the response of endocrine therapy to PC patients varies widely and is currently not yet clinically predictable Prognosis of advanced PC. Some authors believe that the level of AR in cancer tissue on the prognosis of PC endocrine therapy has the value of 〔1〕, AR gene mutation is guided ...